Eloro Resources Ltd. Commences Trading on OTCQX
TORONTO, Aug. 20, 2020 (GLOBE NEWSWIRE) — Eloro Resources Ltd. (TSX-V: ELO; OTCQX: ELRRF; FSE: P2Q) (“Eloro”, or the “Company”) […]
ProntoForms Reports Q2 2020 Financial Results
OTTAWA, Aug. 20, 2020 (GLOBE NEWSWIRE) — ProntoForms Corporation (TSXV: PFM), the global leader in field-focused low-code application platforms for […]
Vanstar Announces the Nominees for Its Upcoming Annual General Meeting
THIS RELEASE MAY NOT BE DISTRIBUTED TO US WIRE SERVICES FOR UNITED STATES DISTRIBUTION.MONTREAL, Aug. 20, 2020 (GLOBE NEWSWIRE) — […]
Vitalhub Corp. Announces Acquisition of Intouch With Health Inc.
TORONTO, Aug. 20, 2020 (GLOBE NEWSWIRE) — VITALHUB CORP. (TSXV: VHI) (the “Company” or “VitalHub”), is pleased to announce today […]
Global Property Manager Deepens Legend Power® Partnership to Drive Results
VANCOUVER, British Columbia, Aug. 20, 2020 (GLOBE NEWSWIRE) — Legend Power® Systems (TSX-V: LPS), a global leader in commercial electrical […]
Matinas BioPharma Announces Publication of Results from Phase 1 Portion of the EnACT Study Investigating Safety and Tolerability of MAT2203
BEDMINSTER, N.J., Aug. 20, 2020 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), today announced the publication of […]
Methode Electronics to Announce First Quarter Fiscal 2021 Results on Thursday, September 3, 2020
CHICAGO, Aug. 20, 2020 (GLOBE NEWSWIRE) — Methode Electronics, Inc. (NYSE: MEI), a global developer of custom engineered and application […]
Class 1 Nickel and Technologies Limited Commences Trading on the Canadian Securities Exchange under the Stock Symbol “NICO”
TORONTO, Aug. 20, 2020 (GLOBE NEWSWIRE) — Class 1 Nickel and Technologies Limited (“Class 1 Nickel” or the “Company”) (CSE: […]
EyePoint Pharmaceuticals Receives $9.5 Million in Upfront Cash from Ocumension Therapeutics Under Expanded License Agreements
WATERTOWN, Mass., Aug. 20, 2020 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing […]
Annovis Bio Actively Recruiting Patients for its Phase 2a Trials in Alzheimer’s and Parkinson’s Diseases
BERWYN, Pa., Aug. 20, 2020 (GLOBE NEWSWIRE) — Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing […]
